Retrospective evaluation of mild encephalitis/encephalopathy with a reversible splenial lesion in children

Fuente: Wiley Open Access
Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Xin Li, Suzhen Sun, Huifeng Zhang
Format: Artículo Open Access
Veröffentlicht: Wiley 2025
Schlagworte:
Online-Zugang:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
_version_ 1867010164287078400
author Xin Li
Suzhen Sun
Huifeng Zhang
author_facet Xin Li
Suzhen Sun
Huifeng Zhang
Xin Li
Suzhen Sun
Huifeng Zhang
collection Wiley Open Access
contents Retrospective evaluation of mild encephalitis/encephalopathy with a reversible splenial lesion in children Xin Li Suzhen Sun Huifeng Zhang Pediatrics International Abstract Background Comprehensive documentation on consecutive years of mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) in children is lacking. This study aims to provide an in‐depth analysis of the clinical profiles of MERS in children across different age groups, focusing on pathogens and recovery time. Methods In this retrospective study, 43 patients diagnosed with MERS were enrolled between December 2017 and November 2021. Due to different clinical manifestations at different ages, we categorized them into two age groups: the 6‐year‐old or younger group and the over 6‐year‐old group. Clinical data were described and compared for these age cohorts. Results Sixty percent of the cases occurred during winter, with two distinct peaks in onset age, at 1–3 years of age and 7–8 years of age. Intestinal infections were prevalent among children aged below 6 years, mainly caused by rotavirus; convulsion was the most common symptom (92.6% vs. 50%, p  = 0.005). Conversely, respiratory tract infections were often observed in children older than 6 years of age, which were mainly attributed to mycoplasma pneumonia; headache and dizziness were characteristic symptoms (62.5% vs. 18.5%, p  = 0.003). No significant differences were found in treatment outcomes between the two age groups. Nonetheless, MERS type II exhibited a notably longer clinical recovery time than type I (4.8 ± 1.7 vs. 8.2 ± 5.5). Conclusion Mild encephalitis/encephalopathy with a reversible splenial lesion exhibits a distinct seasonal pattern with varied clinical manifestations across different age groups. Although the prognosis was favorable, discernible differences in clinical symptoms and pathogens were observed between the two age cohorts. It was noted that the clinical recovery time for MERS type II was comparatively protracted in comparison with type I. 10.1111/ped.15869 http://onlinelibrary.wiley.com/termsAndConditions#vor
doi_str_mv 10.1111/ped.15869
format Artículo Open Access
id wiley_oa_10_1111_ped_15869
institution Wiley Open Access
license_str_mv http://onlinelibrary.wiley.com/termsAndConditions#vor
publishDate 2025
publisher Wiley
record_format wiley_oa
spellingShingle Retrospective evaluation of mild encephalitis/encephalopathy with a reversible splenial lesion in children
Xin Li
Suzhen Sun
Huifeng Zhang
Pediatrics International
Retrospective evaluation of mild encephalitis/encephalopathy with a reversible splenial lesion in children Xin Li Suzhen Sun Huifeng Zhang Pediatrics International Abstract Background Comprehensive documentation on consecutive years of mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) in children is lacking. This study aims to provide an in‐depth analysis of the clinical profiles of MERS in children across different age groups, focusing on pathogens and recovery time. Methods In this retrospective study, 43 patients diagnosed with MERS were enrolled between December 2017 and November 2021. Due to different clinical manifestations at different ages, we categorized them into two age groups: the 6‐year‐old or younger group and the over 6‐year‐old group. Clinical data were described and compared for these age cohorts. Results Sixty percent of the cases occurred during winter, with two distinct peaks in onset age, at 1–3 years of age and 7–8 years of age. Intestinal infections were prevalent among children aged below 6 years, mainly caused by rotavirus; convulsion was the most common symptom (92.6% vs. 50%, p  = 0.005). Conversely, respiratory tract infections were often observed in children older than 6 years of age, which were mainly attributed to mycoplasma pneumonia; headache and dizziness were characteristic symptoms (62.5% vs. 18.5%, p  = 0.003). No significant differences were found in treatment outcomes between the two age groups. Nonetheless, MERS type II exhibited a notably longer clinical recovery time than type I (4.8 ± 1.7 vs. 8.2 ± 5.5). Conclusion Mild encephalitis/encephalopathy with a reversible splenial lesion exhibits a distinct seasonal pattern with varied clinical manifestations across different age groups. Although the prognosis was favorable, discernible differences in clinical symptoms and pathogens were observed between the two age cohorts. It was noted that the clinical recovery time for MERS type II was comparatively protracted in comparison with type I. 10.1111/ped.15869 http://onlinelibrary.wiley.com/termsAndConditions#vor
title Retrospective evaluation of mild encephalitis/encephalopathy with a reversible splenial lesion in children
topic Pediatrics International
url https://onlinelibrary.wiley.com/doi/10.1111/ped.15869